Accordius Health At Greensboro, Llc | |
1201 Carolina Street, Greensboro, North Carolina 27401 | |
(336) 522-5700 | |
Name | Accordius Health At Greensboro, Llc |
---|---|
Location | 1201 Carolina Street, Greensboro, North Carolina |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 105 |
Occupancy Rate | 55.71% |
Medicare ID (CCN) | 345014 |
Legal Business Name | Accordius Health At Greensboro Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1154194306 |
Organization Name | CAROLINA STREET OPERATING COMPANY, LLC |
Address | 1201 Carolina St, Greensboro, NC 27401 |
Phone Number | 336-522-5700 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.
According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.
Anticipation regarding the Supreme Court's health law decision - expected this week and possibly even today - has created a guessing-game situation in Washington. News outlets report on both the preparations being made and the reasons why this decision, and the challenge behind it, are historic and important.
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.
Jose Augusto Barreto-Filho, M.D., Ph.D., of the Federal University of Sergipe and the Clinica e Hospital Sao Lucas, Sergipe, Brazil, and colleagues assessed procedure rates and outcomes of surgical aortic valve replacement (AVR) among 82,755,924 Medicare fee-for-service beneficiaries between 1999 and 2011.
› Verified 2 days ago
NPI Number | 1649720947 |
Organization Name | GREENSBORO OPERATING COMPANY LLC |
Doing Business As | FISHER PARK HEALTH AND REHABILITATION CENTER |
Address | 1201 Carolina St, Greensboro, NC 27401 |
Phone Number | 336-275-0751 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.
According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.
Anticipation regarding the Supreme Court's health law decision - expected this week and possibly even today - has created a guessing-game situation in Washington. News outlets report on both the preparations being made and the reasons why this decision, and the challenge behind it, are historic and important.
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.
Jose Augusto Barreto-Filho, M.D., Ph.D., of the Federal University of Sergipe and the Clinica e Hospital Sao Lucas, Sergipe, Brazil, and colleagues assessed procedure rates and outcomes of surgical aortic valve replacement (AVR) among 82,755,924 Medicare fee-for-service beneficiaries between 1999 and 2011.
› Verified 2 days ago
NPI Number | 1689147035 |
Organization Name | ACCORDIUS HEALTH AT GREENSBORO LLC |
Doing Business As | LINDEN PLACE CENTER FOR NURSING AND REHABILITATION |
Address | 1201 Carolina St, Greensboro, NC 27401 |
Phone Number | 336-522-5700 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.
According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.
Anticipation regarding the Supreme Court's health law decision - expected this week and possibly even today - has created a guessing-game situation in Washington. News outlets report on both the preparations being made and the reasons why this decision, and the challenge behind it, are historic and important.
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.
Jose Augusto Barreto-Filho, M.D., Ph.D., of the Federal University of Sergipe and the Clinica e Hospital Sao Lucas, Sergipe, Brazil, and colleagues assessed procedure rates and outcomes of surgical aortic valve replacement (AVR) among 82,755,924 Medicare fee-for-service beneficiaries between 1999 and 2011.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.
According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.
Anticipation regarding the Supreme Court's health law decision - expected this week and possibly even today - has created a guessing-game situation in Washington. News outlets report on both the preparations being made and the reasons why this decision, and the challenge behind it, are historic and important.
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.
Jose Augusto Barreto-Filho, M.D., Ph.D., of the Federal University of Sergipe and the Clinica e Hospital Sao Lucas, Sergipe, Brazil, and colleagues assessed procedure rates and outcomes of surgical aortic valve replacement (AVR) among 82,755,924 Medicare fee-for-service beneficiaries between 1999 and 2011.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $15184 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 23.24 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.57 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 62.5 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.16 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.95 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.37 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 65.56 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 10.67 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 23.92 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 34.23 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.67 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.85 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 93.58 | 95.98 |
Percentage of short-stay residents who made improvements in function | 71.34 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 32.06 | 82.93 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.
According to the Preventive Services Task Force in the U.S., routine testing for mutations in the BRCA1 and BRCA2 genes, which have been linked to breast and ovarian cancer, are not advised unless women have a family history of the disease.
Anticipation regarding the Supreme Court's health law decision - expected this week and possibly even today - has created a guessing-game situation in Washington. News outlets report on both the preparations being made and the reasons why this decision, and the challenge behind it, are historic and important.
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.
Jose Augusto Barreto-Filho, M.D., Ph.D., of the Federal University of Sergipe and the Clinica e Hospital Sao Lucas, Sergipe, Brazil, and colleagues assessed procedure rates and outcomes of surgical aortic valve replacement (AVR) among 82,755,924 Medicare fee-for-service beneficiaries between 1999 and 2011.
› Verified 2 days ago
Blumenthal Nursing & Rehabilitation Center Location: 3724 Wireless Drive, Greensboro, North Carolina 27455 Phone: (336) 540-9991 | |
Accordius Health At Greensboro, Llc Location: 1201 Carolina Street, Greensboro, North Carolina 27401 Phone: (336) 522-5700 | |
Carolina Pines At Greensboro, Llc Location: 109 S Holden Rd, Greensboro, North Carolina 27407 Phone: (336) 522-5600 | |
Greenhaven Health And Rehabilitation Center Location: 801 Greenhaven Drive, Greensboro, North Carolina 27406 Phone: (336) 292-8371 | |
Friends Homes At Guilford Location: 925 New Garden Road, Greensboro, North Carolina 27410 Phone: (336) 292-8187 | |
Kindred Hospital East Greensboro Location: 2401 South Side Boulevard, Greensboro, North Carolina 27406 Phone: (336) 271-2800 |